Navigation Links
Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo
Date:10/19/2013

ST. LOUIS (PRWEB) October 19, 2013

The GranuFlo recall lawyers at Baron and Budd are reviewing GranuFlo claims relating to the March 2012 GranuFlo and NaturaLyte recall. Dialysis concentrates used during dialysis treatments to help clean the blood, both GranuFlo and NaturaLyte are manufactured and marketed by Fresenius Medical Care, the world's largest provider of dialysis products. Both dialysis concentrates were recalled by the Food and Drug Administration (FDA) as a Class I recall, the highest form of drug recall in the United States used only when a medical product can cause serious health conditions or even death. (http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm309990.htm)

Dialysis patients or their loved ones may be eligible to file a GranuFlo lawsuit with Baron and Budd's GranuFlo recall lawyers if they suffered from a heart attack during or following a dialysis treatment. This dialysis treatment may have involved the use of GranuFlo or NaturaLyte and therefore could be the cause of the patient's injury.

At this time, Baron and Budd is continuing to review GranuFlo lawsuit claims, providing individuals who may be eligible to file a GranuFlo lawsuit claim with a free legal consultation. All consultations are confidential.

The risk of heart attack associated with the use of GranuFlo and NaturaLyte involves the increased bicarbonate associated with these particular dialysis concentrates. Both GranuFlo and NaturaLyte are more likely to cause a higher level of bicarbonate in the blood compared to other dialysis concentrates in their class. As doctors were uninformed of the increased bicarbonate associated with GranuFlo and NaturaLyte, patients were in turn put at risk for heart attacks allegedly caused by an overdose of bicarbonate. (http://www.prweb.com/releases/2013/5/prweb10700127.htm)

"The FDA does not take Class I recalls lightly. These recalls occur only when there is a reasonable probability that the product could cause serious health condition or even death," says Russell Budd of Baron and Budd. “While the Class I recall is an important step in ensuring dialysis patient safety, work needs to be done to help patients who have already been injured. Our GranuFlo lawyers are taking the necessary steps to help these injured patients by providing confidential and free consultations to patients who have suffered heart attacks following dialysis treatment."

To learn more about Baron and Budd's work on the GranuFlo lawsuit please visit the firm's website at http://baronandbudd.com/areas-of-practice/pharmaceuticals/granuflo-lawyer/

To speak with a GranuFlo lawyer as part of Baron and Budd's free and confidential GranuFlo recall consultations, please call 1.866.472.9108.

About Baron & Budd, P.C.

With a history of over 35 years “Protecting What’s Right” for individuals, communities, and governmental entities, Baron and Budd is a well-established law firm devoted to making a positive difference. With offices in Dallas, Austin, Los Angeles and Baton Rouge, Baron and Budd is able to take on complicated and expensive cases within the realms of dangerous drugs and medical devices, asbestos-related illnesses, consumer fraud, water contamination, the Gulf oil spill and fraudulent financial practices.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11248646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The National Plaintiff’s Law Firm of Baron and Budd Handling Granuflo Recall Lawsuits
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Baron and Budd Supports the Newest Drug Being Tested for Mesothelioma Treatment
4. Baron and Budd Has Begun Investigating Claims for Transvaginal Mesh Lawsuits
5. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
6. Baron and Budd is Encouraged by the First Federal Transvaginal Mesh Lawsuit Verdict
7. Baron and Budd Announces Second Transvaginal Mesh Lawsuit Settlement for Bard
8. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
9. GranuFlo Recall Website Launched By Hissey Kientz, LLP Law Firm
10. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
11. GranuFlo Lawsuits Filed in Wake of GranuFlo and NaturaLyte Recall Mount in State and Federal Courts, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology: